Abdominal-perineal resection,c02.15;c02.16;c08.9,Abortion risk factor,c43.4,Acetaminophen,p19.7;c04.4,Achlorhydria,c39.4,Acromegaly,c34.1,ACTH-producing tumor,c34.1;c34.5;c34.6,Actinomycin-D,8,Active-specific immunotherapy,c25.17,Active stimulation immunotherapy,p08.5,Activity,p16.21;p16.22;p16.23;p17.5;p17.6;p17.7;,Acupressure,p25.7,Acute leukemia,6,Acyclovir,p17.18;p20.7,Addiction,p19.11,Addison's disease,c41.2,Adenocarcinoma,20,Adenoma,4,Adenosquamous carcinoma,3,Adjunctive therapies unproven,p13.8,Adjuvant therapy,3,Adoptive immunotherapy,p08.6,Adrenal gland cancer,12,Adrenal insufficiency,c41.2,Adrenergic blockers,c08.8,Adrenocortical carcinoma,c01.2;c01.9;c01.12,Adriamycin,21,Advance Directive,p32.4,Affirmation,p29.9,Age,12,AIDS,5,AlDS-related cancers,p01.8,Albinism,c37.5,Alcohol,3,Aldosteronoma,c01.1,Alkaloids,p07.6,Alkeran,6,Alkylating agents,p07.6;p11.5;c04.6;c28.12;c28.14,Allergic reaction to biological therapy,p08.18,Allogeneic bone marrow transplantation,p12.5,Allopurinol,c18.25,Alternative medicine,p13.15,American Cancer Society (ACS),9,American College of Obstetricians and Gynecologists,p34.19;c09.7,American College of Physicians,p34.19,American College of Surgeons,p34.19,American Medical Association,p13.14,American Society of Clinical Oncology,p12.14,American Society of Hematology,p12.14,American Stop Smoking Intervention Study (ASSIST),p34.24,Americans with Disabilities Act (1990),p31.9,Amifostine,p35.17,Amine precursor uptake and decarboxylation (APUD) tumor,c08.1;c08.2;c21.2,Amphogel,p06.18,Amphotericin B,p20.7,Amsacrine,p35.12;c18.18,Anabolic steroids,c19.3,Anagrelide,c18.26,Anal cancer,12,Anal margin cancer,c02.3,Analgesics,2,Anaphylaxis from biological therapy,p08.18,Anaplastic carcinoma thyroid,c42.23,Anaplastic seminoma testis cancer,c40.1,Anemia,p02.6;c39.3;c39.7;c41.2,Anesthesia,2,Anesthesiologist role,p05.16,Aneuploid tumor,c11b.8,Anger,p03.14;p16.9,Angiography,p02.19,Angiosarcoma,2,Anorexia,p17.20,Antacids,p17.23,Anthrapyrazoles,c06.48,Antiandrogens,c35.18;c35.29,Antibiotics,3,Antibodies,13,Anticipatory nausea and vomiting,p17.13,Anticonvulsants,p19.8,Antidepressants,p17.23;p19.8;p23.8,Antiemetics,p17.14,Antifolate compounds,p35.8,Antifungal drugs,p20.7,Antigens,3,Antihistamines,p19.8,Antihypertensive drugs,p23.8,Antimetabolites,p07.6;p35.9;p35.10,Antinausea drugs,p17.14,Antispasmodics,p17.23,Antitumor antibiotics,p07.6,Antiviral drugs,p19.5;p20.7,Apheresis,p14.8,Appendectomy,c08.9,Appendiceal carcinoid,c08.9,Appetite loss of,p17.20;p18.2,Ara-C for ovarian cancer,c29.20,Armpit lymph nodes cancer of unknown primary site,c07.14,Asbestos,p01.7;p34.7;c26.2;c26.3,L-Asparaginase,c18.19,Aspirin,p19.8;p27.6,Association of Pediatric Oncology Nurses (APON),p15.3,Astrocytoma,7,Atarax,c03.17,Ataxia telangiectasia,c10a.5,Ativan,p17.14;chr.p17.14;p18.20;c18.17,Atypical hyperplasia,c06.5,Autologous blood transfusion,p14.10,Autologous bone marrow transplantation,p08.15;p12.6,Autologous peripheral stem cell transplant,p12.6,Azacitidine,p35.12,5-Azacytidine,c26.11,AZT,c16.16;c16.18,
for bone and soft tissue sarcomas,c36.11,for Ewing's sarcoma,c10d.11,for ovarian cancer,c30.14;c30.18,for rhabdomyosarcoma,c10d.4;c10d.6,for testis cancer,chr.c40.17,for trophoblastic disease,c43.13;c43.14;c43.15,for uterine cancer,c45.10;c45.12;c45.14;c45.16,for vaginal cancer,c46.13,defined,c18.2,lymphoblastic,c10a.1;c10a.14;c10a.16;c18.19,lymphocytic,c10a.5;c18.1,myeloblastic,c18.17,non-lymphoblastic,c10a.1;c10a.16,treatment,c18.13,anus,c02.2,bile duct,c03.1,bladder,c04.3;c04.25,breast,c06.3,cervix,c09.1;c09.7;c09.12;c09.15,colorectal,c11a.2,endometrium,c44.1,esophagus,c12.2,gall bladder,c13.1,intraductal,c35.32,kidney,c17.2,liver,c19.1;c19.17,lung,c20.2,pancreas,c31.1,prostate,c35.2,small intestine,c38.2;c38.11,stomach,c39.1,unknown primary site,c07.3,vagina,c46.1;c46.9;c46.10;c46.11,vulva,c47.2;c47.18,adrenocortical,c01.2,chromophobe,c34.1;c34.7,cortical,c01.2,pituitary,c05.19,cervix,c09.2;c09.7,endometrium,c44.2,pancreas,c31.1,after surgery,p07.3,chemotherapy,p04.6;p07.15,immunotherapy,p08.5,child,c01.2,diagnosis,c01.7,follow-up,c01.17,questions to ask,c01.19,recurrence,c01.18,risk factors,c01.4,screening,c01.5,spread,c01.3,staging,c01.9,symptoms,c01.6,treatment,c01.10,types,c01.2,for anal cancer,c02.19,for bladder cancer,c04.18;c04.24,for bone and soft tissue sarcomas,c36.11,for breast cancer,c06.24;c06.37;c06.39;c06.42;c06.48,for esophageal cancer,c12.20,for gastrointestinal cancer,c08.13,for Hodgkin's disease,c23.15;c23.17,for islet cell carcinoma,c15.10,for Kaposi's sarcoma,c16.16;c16.21,for leukemia,c18.19,for liver cancer,c19.11;c19.14;c19.16,for lung cancer,c21.13,for lymphoma,c22.7;c22.8;c24.16;c24.18;c24.19,for multiple myeloma,c28.12;c28.20,for ovarian cancer,c29.19;c29.24,for pancreatic cancer,c31.11;c31.17,for stomach cancer,c39.15;c39.25,for thymus cancer,c41.10,for uterine cancer,c44.13;c44.16;c44.17;c44.19;c44.20;c44.21;c45.10;c45.12;c45.14;c45.16;c45.17,for vaginal cancer,c46.13,side effects,chr.p17.13;p17.38,breast cancer,c06.5;c06.6,colorectal cancer,c11a.4,multiple myeloma,c28.5,pancreatic cancer,c31.3,penile cancer,c33.3,prostate cancer,c35.5,small intestine cancer,c38.4,stomach cancer,c39.5,testis cancer,c40.6,treatment options,p04.12,trophoblastic disease,c43.4,uterine sarcoma,c45.4,blood transfusion,p14.3;p14.14,brain tumor,c05.2,CNS lymphoma,c05.20,Kaposi's sarcoma,c16.1;c16.3;c16.4;c16.5;c16.6;c16.7;c16.8;c16.13;c16.14;c16.16,lymphoma,c22.1,mouth irritant,p17.19,risk factor,p01.8;p34.12;c12.3;c12.4;c14a.5;c31.3,and sexual dysfunction,p23.8,for breast cancer,c06.37,for Hodgkin's disease,c23.17,for multiple myeloma,c28.12,for ovarian cancer,c29.24,may cause bladder cancer,c04.4,may cause nausea,chr.p17.13,fight against cancer,p34.23,Look Good Feel Better,p22.1,on screening,chr.p01.19,on unproven therapies,p13.14,Reach to Recovery,p23.10,referrals,p03.8,resources,p03.11;p26.5,Seven Early Warning Signals,p02.2,support groups,p16.17;p16.18,causes,c02.2,diagnosis,c02.6,follow-up,c02.18,questions to ask,c02.20,recurrence,c02.19,risk factors,c02.3,screening,c02.4,spread,c02.2,staging,c02.8,symptoms,c02.5,treatment,p09.8;c02.9,types,c02.1,defined,p27.6,post-operative pain,p05.17;p05.18,risks,p05.19,types,p05.15,liver,c19.1;c19.17;chr.c36.2,small intestine,c38.2,antitumor,p07.6,causing diarrhea,p17.28,to fight infection,p20.9,immune response,p08.3,monoclonal (MAbs) about,p08.13,for breast cancer,c06.42;c06.48,for colorectal cancer,c11b.21;c11b.25;c11c.14,for kidney cancer,c17.11,for leukemia,c18.20;c18.23,for liver cancer,c19.13,for melanoma,c25.18,for ovarian cancer,c29.20,for stomach cancer,c39.17,parts,p08.13,polyclona,c19.15,side effects,p08.16;p08.18,and bone marrow transplantation,p12.6,defined,p08.3,in donated blood,p14.4;p14.5;p14.6,anaplastic,c10b.15,cerebellar,c10b.11,cerebral,c10b.14;c10b.15,child,c10b.2;c10b.11;c10b.14;c10b.15,defined,c05.1,spinal cord,c05.23,treatment,c05.11;c05.16,
